Background Statins reportedly improve clinical outcomes for ischemic stroke patients.
However, it is unclear whether the contribution of statin treatment varies depending on the …

Background and purpose: The ability of the National Institutes of Health Stroke Scale
(NIHSS) score to predict functional outcome in minor stroke is controversial. In this study, we …

Background Objectives It is unclear whether IV thrombolysis (IVT) outperforms early dual
antiplatelet therapy (DAPT) in the acute setting of mild ischemic stroke. The aim of this study …

BACKGROUND: Patients with minor ischemic stroke (MIS) are frequently excluded from
thrombolytic therapy. Denial of therapy to these patients, however, remains controversial …

Background: Acute ischemic stroke due to large-vessel occlusion is a leading cause of
death and disability, and therapeutic time window was limited to 4.5 hour when treated with …

Background and purpose: Few studies have addressed factors that contribute to functional
recovery in people with hemorrhagic stroke. We assessed the value of using pre-training …

Background Predicting outcomes of acute stroke patients initially presenting with mild
neurologic deficits is crucial in decision making regarding thrombolytic therapy. We …

Purpose Patients with minor ischemic stroke (MIS) are at high risk of recurrent ischemic
stroke (RIS). The aim of this study was to evaluate the effects of platelet receptor gene …

В монографии рассмотрены вопросы эпидемиологии и исходов мозгового инсульта, а
также пути снижения бремени данного заболевания. Автором обобщены результаты …

Despite the substantial benefit of intravenous recombinant tissue-type plasminogen activator
(IV rtPA) in improving neurologic outcomes in acute ischemic stroke (AIS) patients, 1, 2 only …